DNA array analysis of altered gene expression in human leukocytes stimulated with soluble and particulate forms of Candida cell wall β-glucan

被引:19
作者
Ishibashi, K
Miura, NN
Adachi, Y
Ogura, N
Tamura, H
Tanaka, S
Ohno, N
机构
[1] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Tokyo 1920392, Japan
[2] Seikagaku Corp, Tokyo Res Inst, Tokyo 207, Japan
关键词
beta-glucan; leukocyte; solubility; microarray;
D O I
10.1016/j.intimp.2003.09.007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We previously reported that 1,3-beta-D-glucan derived from Candida albicans, a pathogenic fungus was obtained by oxidation of the cell wall with sodium hypochlorite (NaClO). It could be solubilized by treatment with dimethylsulfoxide (DMSO). We found that OX-CA and CSBG showed significantly different levels of activity toward leukocytes. Here, we have used cDNA microarrays to analyze the mRNA expression of 1176 genes in PBMCs stimulated with Candida cell wall glucan and considered the difference in the activation mechanism of OX-CA and CSBG. Total mRNA showed a significant change for 147 out of 1176 arrayed genes on stimulation with OX-CA and CSBG for 4 It. Among those genes, 62 were common, 26 were OX-CA-specific and 59 were CSBG-specific. Many of these up-regulated genes encode effectors with well-characterized proinflammatory properties. The expression of genes related with signal transduction differed in the particulate and soluble glucans derived from C. albicans having exactly the same primary structure. This fact suggested that each glucan induced specific biological activity through a different activation mechanism. This study using cDNA microarrays to analyze a broad spectrum of mRNA expression provides information on the biological activity of Candida cell wall glucan as a potential pathogenic factor. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:387 / 401
页数:15
相关论文
共 39 条
[21]   PLASMA (1-]3)-BETA-D-GLUCAN MEASUREMENT IN DIAGNOSIS OF INVASIVE DEEP MYCOSIS AND FUNGAL FEBRILE EPISODES [J].
OBAYASHI, T ;
YOSHIDA, M ;
MORI, T ;
GOTO, H ;
YASUOKA, A ;
IWASAKI, H ;
TESHIMA, H ;
KOHNO, S ;
HORIUCHI, A ;
ITO, A ;
YAMAGUCHI, H ;
SHIMADA, K ;
KAWAI, T .
LANCET, 1995, 345 (8941) :17-20
[22]  
Ohno N., 1996, Pharmaceutical and Pharmacological Letters, V6, P115
[23]   Solubilization of yeast cell-wall β-(1→3)-D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction [J].
Ohno, N ;
Uchiyama, M ;
Tsuzuki, A ;
Tokunaka, K ;
Miura, NN ;
Adachi, Y ;
Aizawa, MW ;
Tamura, H ;
Tanaka, S ;
Yadomae, T .
CARBOHYDRATE RESEARCH, 1999, 316 (1-4) :161-172
[24]  
OHNO N, 1996, RECENT RES DEV CHEM, V1, P23
[25]  
Ohshima Y, 1997, J IMMUNOL, V159, P3838
[26]   Ligation of CD11b and CD11c β2 integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1α (MIP-1α) and MIP-1β production in primary human monocytes through a pathway dependent on nuclear factor-κB [J].
Rezzonico, R ;
Imbert, V ;
Chicheportiche, R ;
Dayer, JM .
BLOOD, 2001, 97 (10) :2932-2940
[27]   Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1->3)-beta-D-glucan [J].
Sakurai, T ;
Kaise, T ;
Yadomae, T ;
Matsubara, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 334 (2-3) :255-263
[28]   Signaling through focal adhesion kinase [J].
Schlaepfer, DD ;
Hauck, CR ;
Sieg, DJ .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1999, 71 (3-4) :435-478
[29]   ACTIVATION OF THE COMPLEMENT-SYSTEM BY (1-]3)-BETA-D-GLUCANS HAVING DIFFERENT DEGREES OF BRANCHING AND DIFFERENT ULTRASTRUCTURES [J].
SUZUKI, T ;
OHNO, N ;
SAITO, K ;
YADOMAE, T .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1992, 15 (06) :277-285
[30]   Immunopharmacological activity of the purified insoluble glucan, zymocel, in mice [J].
Suzuki, T ;
Ohno, N ;
Chiba, N ;
Miura, NN ;
Adachi, Y ;
Yadomae, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (12) :1243-1248